Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Robb

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1984
The systemic administration of purified interleukin 2 enhances the ability of sensitized murine lymphocytes to cure a disseminated syngeneic lymphomaJ H Donohue, M Rosenstein, A E Chang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1986
Effect of cyclosporin A and dexamethasone on interleukin 2 receptor gene expressionJ C Reed, A H Abidi, J D Alpers, et al.
The Journal of Experimental Medicine|July 1, 1985
Stable expression of cDNA encoding the human interleukin 2 receptor in eukaryotic cellsW C Greene, R J Robb, P B Svetlik, et al.
Cytokine|October 29, 2000
A comparison of biodistribution of liposomal and soluble IL-2 by a new method based on time-resolved fluorometry of europiumM E Neville, K W Richau, L T Boni, et al.
Biochimica Et Biophysica Acta|September 15, 2001
The effect of cholesterol in a liposomal Muc1 vaccineM M Batenjany, L T Boni, Y Guo, et al.
The Journal of Experimental Medicine|October 1, 1990
Increased expression of the interleukin 2 (IL-2) receptor beta chain (p70) on CD56+ natural killer cells after in vivo IL-2 therapy: p70 expression does not alone predict the level of intermediate affinity IL-2 bindingS D Voss, R J Robb, G Weil-Hillman, et al.
Cancer Research|April 1, 1984
In vivo administration of purified Jurkat-derived interleukin 2 in miceJ H Donohue, M T Lotze, R J Robb, et al.
Biochemistry|December 11, 1979
Complete amino acid sequence of a papain-solubilized human histocompatibility antigen HLA-B7. 1. Isolation and amino acid composition of fragments and of tryptic and chymotryptic peptidesJ A López de Castro, H T Orr, R J Robb, et al.
Current Topics in Microbiology and Immunology|January 1, 1984
Interleukin-2 receptors on activated malignant and normal B-cellsT A Waldmann, C K Goldman, W J Leonard, et al.
The Journal of Experimental Medicine|October 1, 1983
Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cellsE A Grimm, R J Robb, J A Roth, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1984
The systemic administration of purified interleukin 2 enhances the ability of sensitized murine lymphocytes to cure a disseminated syngeneic lymphomaJ H Donohue, M Rosenstein, A E Chang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1986
Effect of cyclosporin A and dexamethasone on interleukin 2 receptor gene expressionJ C Reed, A H Abidi, J D Alpers, et al.
The Journal of Experimental Medicine|July 1, 1985
Stable expression of cDNA encoding the human interleukin 2 receptor in eukaryotic cellsW C Greene, R J Robb, P B Svetlik, et al.
Cytokine|October 29, 2000
A comparison of biodistribution of liposomal and soluble IL-2 by a new method based on time-resolved fluorometry of europiumM E Neville, K W Richau, L T Boni, et al.
Biochimica Et Biophysica Acta|September 15, 2001
The effect of cholesterol in a liposomal Muc1 vaccineM M Batenjany, L T Boni, Y Guo, et al.
The Journal of Experimental Medicine|October 1, 1990
Increased expression of the interleukin 2 (IL-2) receptor beta chain (p70) on CD56+ natural killer cells after in vivo IL-2 therapy: p70 expression does not alone predict the level of intermediate affinity IL-2 bindingS D Voss, R J Robb, G Weil-Hillman, et al.
Cancer Research|April 1, 1984
In vivo administration of purified Jurkat-derived interleukin 2 in miceJ H Donohue, M T Lotze, R J Robb, et al.
Biochemistry|December 11, 1979
Complete amino acid sequence of a papain-solubilized human histocompatibility antigen HLA-B7. 1. Isolation and amino acid composition of fragments and of tryptic and chymotryptic peptidesJ A López de Castro, H T Orr, R J Robb, et al.
Current Topics in Microbiology and Immunology|January 1, 1984
Interleukin-2 receptors on activated malignant and normal B-cellsT A Waldmann, C K Goldman, W J Leonard, et al.
The Journal of Experimental Medicine|October 1, 1983
Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cellsE A Grimm, R J Robb, J A Roth, et al.
Pageof 8